Skip to main content

OptiBiotix confirms plan to list skin care subsidiary

OptiBiotix confirms plan to list skin care subsidiary

Life sciences group OptiBiotix Health plc (LON:OPTI) has confirmed its majority owned SkinBioTherapeutics subsidiary is looking to list on AIM. The group has been gearing up for this ever since it announced plans to spin out the skin care business – formerly known as SkinBiotix – last summer.

Shortly after announcing the split, OptiBiotix brought in Martin Hunt as its new chairman, while Catherine O’Neill has since been appointed as chief executive to head up the new business.

See the article in full at ProactiveInvestors.co.uk